ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+115.7%
5Y CAGR+44.9%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+115.7%/yr
Annual compound
5Y CAGR
+44.9%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
6.4x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 173.32% |
| 2024 | 39.61% |
| 2023 | -25.18% |
| 2022 | 17.28% |
| 2021 | -15.85% |
| 2020 | 27.09% |
| 2019 | -37.47% |
| 2018 | -15.90% |
| 2017 | 17.06% |
| 2016 | -71.35% |